has a place in the effort to avert acute attacks; however, its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward ...

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

Arterial-Blood Studies during Treatment of Severe Refractory Bronchial Asthma in Case 2 on May 17, after Theophylline and Epinephrine (1), at 8:00 A.M., when the Asthma Was Refractory to ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca ... Airsupra was found to significant reduce the risk of severe exacerbations compared to albuterol in patients with ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

The allergy and immunology community mourns the loss of Marcus Maurer, MD, executive director of the Institute of Allergology ...

In asthma, lower end-tidal carbon dioxide may predict acute exacerbation outcomes, although other measures may be better severity indicators.

"For me, preventing exacerbations, and particularly those that lead to hospitalisations, is a treatment priority for the people I see with severe asthma," he added. "Not only are exacerbations ...

The following is a summary of “Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis,” published in ...

Marianne Baastrup Soendergaard, Department of Respiratory Medicine, Copenhagen University Hospital–Bispebjerg, Copenhagen, ...

Researchers at McMaster University have made an important discovery in the field of asthma research, identifying a new ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...